KRX Growth Stocks With High Insider Ownership In October 2024

Over the last seven days, the South Korean market has remained flat, yet it has seen a 7.3% rise over the past year with earnings anticipated to grow by 29% annually in the coming years. In this context of steady growth and promising future earnings, companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those who know the business best.

Top 10 Growth Companies With High Insider Ownership In South Korea

Name	Insider Ownership	Earnings Growth
People & Technology (KOSDAQ:A137400)	16.4%	35.6%
Seojin SystemLtd (KOSDAQ:A178320)	30.7%	49.1%
HANA Micron (KOSDAQ:A067310)	18.3%	105.8%
Bioneer (KOSDAQ:A064550)	15.8%	97.6%
Oscotec (KOSDAQ:A039200)	26.1%	122%
ALTEOGEN (KOSDAQ:A196170)	26.6%	99.5%
Vuno (KOSDAQ:A338220)	19.4%	110.9%
Park Systems (KOSDAQ:A140860)	33%	34.6%
UTI (KOSDAQ:A179900)	33.1%	134.6%
Techwing (KOSDAQ:A089030)	18.7%	83.6%

Click here to see the full list of 88 stocks from our Fast Growing KRX Companies With High Insider Ownership screener.

Here we highlight a subset of our preferred stocks from the screener.

Medy-Tox (KOSDAQ:A086900)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Medy-Tox Inc. is a South Korean biopharmaceutical company with a market cap of ₩1.17 trillion.

Operations: The company's revenue from its biotechnology segment is ₩246.25 billion.

Insider Ownership: 19.8%

Earnings Growth Forecast: 62% p.a.

Medy-Tox is experiencing significant earnings growth, forecasted at 62% annually, surpassing the South Korean market's average. Despite a decline in profit margins from last year, the stock trades significantly below its estimated fair value. Analysts agree on a potential price increase of 48.3%. The company has announced a share buyback program to stabilize stock prices and enhance shareholder value, reflecting strong insider confidence despite no recent substantial insider trading activity.

• Click here and access our complete growth analysis report to understand the dynamics of Medy-Tox.
• The valuation report we've compiled suggests that Medy-Tox's current price could be quite moderate.

SungEel HiTech (KOSDAQ:A365340)

Simply Wall St Growth Rating: ★★★★★☆

Overview: SungEel HiTech Co., Ltd. is a South Korean company specializing in secondary battery recycling, with a market cap of ₩656.63 billion.

Operations: The company's revenue is primarily generated from its Secondary Battery Raw Material Manufacturing segment, totaling ₩196.64 billion.

Insider Ownership: 38%

Earnings Growth Forecast: 101.7% p.a.

SungEel HiTech is forecasted to achieve substantial revenue growth of 40% annually, significantly outpacing the South Korean market average. Although its return on equity is expected to remain low at 9.5% in three years, the company trades at a significant discount to its estimated fair value. Despite no substantial insider trading activity recently, SungEel HiTech's anticipated profitability within three years signals potential for robust financial performance amidst current debt challenges.

• Delve into the full analysis future growth report here for a deeper understanding of SungEel HiTech.
• Upon reviewing our latest valuation report, SungEel HiTech's share price might be too optimistic.

APR (KOSE:A278470)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: APR Co., Ltd is a company that manufactures and sells cosmetic products for men and women, with a market cap of ₩403.58 billion.

Operations: The company's revenue is primarily derived from its cosmetics segment, generating ₩614.77 billion, complemented by its apparel fashion segment with ₩64.46 billion.

Insider Ownership: 32.8%

Earnings Growth Forecast: 22.8% p.a.

APR Co., Ltd. is experiencing significant earnings growth, expected to rise 22.77% annually over the next three years, although revenue growth of 19.6% per year is slightly below the desired threshold for high-growth companies. The company recently completed a share buyback and has been added to the S&P Global BMI Index, enhancing its market visibility. Despite high share price volatility, APR trades at a discount to its fair value with no recent insider trading activity noted.

• Get an in-depth perspective on APR's performance by reading our analyst estimates report here.
• Our comprehensive valuation report raises the possibility that APR is priced lower than what may be justified by its financials.

Key Takeaways

• Unlock more gems! Our Fast Growing KRX Companies With High Insider Ownership screener has unearthed 85 more companies for you to explore.Click here to unveil our expertly curated list of 88 Fast Growing KRX Companies With High Insider Ownership.
• Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive.
• Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.

Ready To Venture Into Other Investment Styles?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com